investing

Biotechnology green shoots?

August 26, 2009

With two life science IPOs earlier this month, and seemingly fewer stories of biotechnology firm liquidations, it seems that the tides are turning — ever so slightly — in the favor of biotechnology. Share this page

Read the full article →

VC’s don’t read business plans; So, what to do?

May 15, 2009

A recent UMD study has found that VCs pay little attention ot the content of business plans.This is not much of a surprise. I’m generally bearish on business plans, but I do recognize their important role. Having written several business plans and having successfully competed in business plan competitions, I’ve recognized that many of the [...]

Read the full article →

Creative Destruction in Biotechnology

May 11, 2009

For all the talk of the numerous biotechnology companies with mere months of cash left and the predictions of looming liquidations, mergers, and acquisitions, it is important to note that a measure of destruction can benefit industry progress. Economy Joseph Schumpeter coined a term for industrial progress through destruction: creative destruction. In this process, growth [...]

Read the full article →

Call for papers: Biotechnology Investing

May 29, 2008

The Journal of Commercial Biotechnology is looking for papers on investing strategies in the biotechnology space. The scope can include valuation models, strategies to identify under-valued companies, case studies in developing and managing a portfolio, etc. The Journal of Commercial Biotechnology is a peer-reviewed journal focused on the business of biotechnology. More information, instructions for [...]

Read the full article →